Global Geriatric Medicines Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period.
Geriatrics is a division of medicines related to the remedial, clinical, social, and preventive aspects of ill health generally among the population over & above 65 years. The majority of the geriatrics is not capable to take their medication accurately at the planned time on account of complex psychological and medical issues. The geriatric population needs special attention and care for the rapid revival of disorder or disease.
The growing number of the aging population is a major factor driving the growth of the global geriatric medicines market. In addition, increasing the incidence of chronic diseases and demand for effective therapy is another factor fueling the growth of the global geriatric medicines market.
Furthermore, rapidly developing medical infrastructure, government initiatives, rising health care per person expenditure are also factors expected to drive revenue growth of the global geriatric medicines market. However, the dearth of wakefulness about the accessibility of geriatric care among aged patients in budding countries is a critical factor expected to hamper the market growth.
The report covers the latest trends in the geriatric medicines market such as the government are funding several R&D activities in order to conduct clinical trials for the development of effective treatment procedures. In addition, the government is coming up with different reimbursement policies that are beneficial for the aging population for managing the cost of treatment.
On the basis of the therapeutic category, the antihypertensive segment is expected to dominate the global geriatric medicines market in terms of revenue and expected to maintain its position in the future. This can be primarily attributed to the rising incidences of hypertension among the elderly populace.
Region-wise, the market in North America accounts for a major share of XX% in terms of revenue and is expected to lucrative growth over the forecast period. The growing number of people above 65 age coupled with rising occurrences of age-related disorder and diseases are the factors expected to drive the growth of the geriatric medicines market in countries in the region. Asia Pacific market is expected to witness the fastest growth in terms of revenue over the forecast period.
The objective of the report is to present a comprehensive analysis of the Global Geriatric Medicines Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by Application. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by Application on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Geriatric Medicines Market dynamics, structure by analyzing the market segments and project the Global Geriatric Medicines Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Geriatric Medicines Market make the report investor’s guide.
Scope of the Global Geriatric Medicines Market
Global Geriatric Medicines Market, By Therapeutic Category
• Proton Pump Inhibitor
• Antipsychotic and Antidepressant
• Others (include, anticholinergics, gastrointestinal, etc.)
Global Geriatric Medicines Market, By Condition
• Others (include, Parkinson’s disease, palliative care, etc.)
Global Geriatric Medicines Market, By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Geriatric Medicines Market, By Region
• North America
• Asia Pacific
• Middle East and Africa
• South America
Key players operating in Global Geriatric Medicines Market
• Pfizer, Inc.
• Merck & Co., Inc.
• AstraZeneca plc
• Bristol-Myers Squibb Company
• Novartis AG
• Sanofi S.A
• GlaxoSmithKline plc
• Eli Lilly and Company
• Abbott Laboratories
• Boehringer Ingelheim GmbH
For More Information Visit @:https://www.maximizemarketresearch.com/market-report/global-geriatric-medicines-market/39382/
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address: Pune, Maharashtra 411051, India.